Autologous adipose-derived stem cells therapy in COPD treatment: a case report

Thuy Thanh Nguyen; Phuong Thu Phan; Binh Huy Nguyen; Trang T Thu Vu; Phuong Cam Pham; Giap Van Vu; Khanh Ba Nguyen; Trung Thanh Vu; Luu Dang Vu; Chau Quy Ngo

doi:10.1002/rcr2.748

Autologous adipose-derived stem cells therapy in COPD treatment: a case report

Respirol Case Rep. 2021 Apr 28;9(5):e00748. doi: 10.1002/rcr2.748. eCollection 2021 May.

Authors

Thuy Thanh Nguyen^{1

2}, Phuong Thu Phan^{1

2}, Binh Huy Nguyen^{1

2}, Trang T Thu Vu^{1

2}, Phuong Cam Pham^{1

2}, Giap Van Vu^{1

2}, Khanh Ba Nguyen³, Trung Thanh Vu², Luu Dang Vu², Chau Quy Ngo¹

Affiliations

¹ Hanoi Medical University Hanoi Vietnam.
² Bach Mai Hospital Hanoi Vietnam.
³ National Institute of Hematology and Blood Transfusion Hanoi Vietnam.

Abstract

Here, we describe the clinical course of a patient with chronic obstructive pulmonary disease treated with autologous adipose-derived stem cell therapy. In September 2019, our patient was admitted to Bach Mai Hospital. His post-bronchodilator forced expiratory volume in 1 sec (FEV₁) was 21% and FEV₁/forced vital capacity (FVC) was 40%. He had suffered from two exacerbations of chronic obstructive pulmonary disease (COPD) in the previous year. He received treatment with autologous stem cells from adipose tissue. Follow-up indicated that autologous stem cells from adipose tissue was a safe treatment and improved the patient's dyspnoea and quality of life.

Keywords: Adipose‐derived stem cell; COPD; case report.

Publication types

Case Reports